Startup Of The Week : EW2Health

This week, we’re excited to spotlight EW2Health — the health tech startup redefining obesity care beyond the pill. While GLP-1 drugs have opened a $160B opportunity, EW2Health delivers the missing link: long-term, scalable behavior change. With predictive remote monitoring, emotionally safe smart scales, and real-time insights, they’re doubling treatment success and transforming clinics into next-gen obesity care platforms. The future of weight loss isn’t just medical — it’s behavioral, and EW2Health is leading the way.

1. Tell us about your company. 

Saskia Korink Romani - EW2Health provides the missing link between GLP-1 and long term weight loss, allowing for Scalable and Sustainable Behavior-Based Obesity Treatment.

GLP-1 medications are transforming obesity care, unlocking a $160B global market growing at 19% CAGR. But medication alone isn’t enough—without sustained behavioral change, up to 75% of weight is regained, and clinics struggle with adherence, scalability, and cost-efficiency. This is where EW2Health delivers its value.

EW2Health bridges the critical gap between medical intervention and long-term lifestyle change. Our Predictive Remote Monitoring solution delivers real-time, remote patient monitoring, and drives more than 2-fold improved treatment outcomes. Using emotionally safe, numberless smart scales and the Sinque mobile app, we provide patients with predictive weight trends, while clinics receive actionable insights through a dashboard that flags risk and guides intervention. The predictive behavior monitoring technology provides the glue for an emerging platform, attracting other product and service providers necessary for long term lifestyle change, such as dietitians, wearables, supermarkets and or healthy food offerings.

Our primarily B2B SaaS business is low-CAPEX, highly scalable, and gaining traction in the Netherlands and Brazil. Clinics pay monthly per patient, with rapid ROI driven by improved retention and operational efficiency. Additional revenue streams include integration and startup fees and income from the platform/ecosystem products and services.

2. What made you become an entrepreneur? 

Saskia Korink Romani - I have been working in the corporate world for decades, and finally got tired of large corporations, the politics and the limited impact you have when you work for a big company. So when a scale-up knocked on my door for the first time, I decided to go for it! I never looked back and am now co-founder of our health tech startup, as well as engaged with other start- and scale-ups in different industries.

3. What is the biggest challenge you have faced when looking for funding? 

Saskia Korink Romani - There are many challenges; initially it was to convince investors that obesity is important and needs a solution. Then it was to find the right product-market fit. Now we have the product-market fit, but we are low on resources, and simply cannot handle all the commercial interest we are receiving, and turn that into real sales (= real traction). So we are stuck in this phase where there is a lot going on, but with limited resources we are slow to turn commercial interest into the double digit growth that investors are looking for.

4. What is the most rewarding aspect of entrepreneurship? 

Saskia Korink Romani - The most rewarding aspect of entrepreneurship is the sense of accomplishment and personal satisfaction derived from building and growing a business from the ground up. This includes the freedom and flexibility to make independent decisions, follow a purpose, pursue a vision and - in our case - positively impact millions of lives!

Learn more about the company:https://www.ew2health.com/